FDA OKs Medtronic's New Glucose Monitor

Law360, New York (July 18, 2006, 12:00 AM EDT) -- Medical device maker Medtronic Inc. said Monday it has received U.S. Food and Drug Administration (FDA) approval for a doctor-prescribed continuous glucose monitoring system designed to improve diabetes management.

The Guardian Real-Time System, intended for people who frequently monitor their glucose levels, alerts users to high and low glucose levels. A tiny electrode inserted under the skin, the device allows patients to use real-time data and trend analysis to help control glucose levels, Medtronic said.

“The Guardian Real-Time System is the culmination of more than seven...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.